News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
708,200 Results
Type
Article (40643)
Company Profile (297)
Press Release (667260)
Multimedia
Podcasts (75)
Webinars (12)
Section
Business (207083)
Career Advice (2072)
Deals (35874)
Drug Delivery (100)
Drug Development (82388)
Employer Resources (176)
FDA (16255)
Job Trends (15171)
News (350103)
Policy (32868)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (6)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2574)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (50229)
ALS (90)
Alzheimer's disease (1401)
Antibody-drug conjugate (ADC) (131)
Approvals (16257)
Artificial intelligence (254)
Autoimmune disease (21)
Automation (16)
Bankruptcy (363)
Best Places to Work (11757)
BIOSECURE Act (21)
Biosimilars (108)
Biotechnology (212)
Bladder cancer (78)
Brain cancer (28)
Breast cancer (281)
Cancer (2265)
Cardiovascular disease (178)
Career advice (1728)
Career pathing (33)
CAR-T (151)
Cell therapy (426)
Cervical cancer (19)
Clinical research (67022)
Collaboration (846)
Compensation (531)
Complete response letters (21)
COVID-19 (2613)
CRISPR (39)
C-suite (246)
Cystic fibrosis (101)
Data (2211)
Decentralized trials (2)
Denatured (26)
Depression (46)
Diabetes (269)
Diagnostics (6387)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (120)
Drug pricing (102)
Drug shortages (25)
Duchenne muscular dystrophy (95)
Earnings (87599)
Editorial (42)
Employer branding (23)
Employer resources (150)
Events (114777)
Executive appointments (732)
FDA (17503)
Featured Employer (52)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (749)
Gene editing (105)
Generative AI (20)
Gene therapy (305)
GLP-1 (734)
Government (4461)
Grass and pollen (5)
Guidances (55)
Healthcare (18899)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (114)
Indications (30)
Infectious disease (2755)
Inflammatory bowel disease (138)
Inflation Reduction Act (9)
Influenza (51)
Intellectual property (97)
Interviews (328)
IPO (16744)
IRA (41)
Job creations (3837)
Job search strategy (1469)
Kidney cancer (10)
Labor market (38)
Layoffs (481)
Leadership (21)
Legal (7959)
Liver cancer (75)
Lung cancer (320)
Lymphoma (153)
Machine learning (7)
Management (58)
Manufacturing (307)
MASH (70)
Medical device (13390)
Medtech (13395)
Mergers & acquisitions (19678)
Metabolic disorders (694)
Multiple sclerosis (81)
NASH (16)
Neurodegenerative disease (91)
Neuropsychiatric disorders (29)
Neuroscience (1945)
NextGen: Class of 2025 (6573)
Non-profit (4499)
Northern California (2676)
Now hiring (40)
Obesity (370)
Opinion (222)
Ovarian cancer (76)
Pain (86)
Pancreatic cancer (83)
Parkinson's disease (150)
Partnered (21)
Patents (233)
Patient recruitment (109)
Peanut (46)
People (58152)
Pharmaceutical (76)
Pharmacy benefit managers (19)
Phase I (20915)
Phase II (29573)
Phase III (21917)
Pipeline (1186)
Policy (148)
Postmarket research (2573)
Preclinical (8885)
Press Release (64)
Prostate cancer (107)
Psychedelics (31)
Radiopharmaceuticals (256)
Rare diseases (380)
Real estate (6031)
Recruiting (67)
Regulatory (22530)
Reports (46)
Research institute (2343)
Resumes & cover letters (354)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (129)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2300)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (31)
Startups (3657)
State (2)
Stomach cancer (13)
Supply chain (70)
Tariffs (40)
The Weekly (47)
United States (23201)
Vaccines (701)
Venture capitalists (42)
Weight loss (240)
Women's health (38)
Worklife (19)
Date
Today (158)
Last 7 days (856)
Last 30 days (2714)
Last 365 days (33334)
2025 (10632)
2024 (35730)
2023 (40661)
2022 (51785)
2021 (56339)
2020 (54536)
2019 (46982)
2018 (35385)
2017 (32635)
2016 (32060)
2015 (38110)
2014 (32005)
2013 (26893)
2012 (29013)
2011 (29668)
2010 (27706)
Location
Africa (741)
Alabama (58)
Alaska (7)
Arizona (233)
Arkansas (14)
Asia (39136)
Australia (6324)
California (6119)
Canada (2012)
China (539)
Colorado (269)
Connecticut (275)
Delaware (148)
Europe (84490)
Florida (916)
Georgia (204)
Idaho (57)
Illinois (532)
India (25)
Indiana (309)
Iowa (11)
Japan (160)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (901)
Massachusetts (4596)
Michigan (216)
Minnesota (390)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1732)
New Mexico (29)
New York (1740)
North Carolina (1017)
North Dakota (8)
Northern California (2676)
Ohio (203)
Oklahoma (14)
Oregon (35)
Pennsylvania (1374)
Puerto Rico (13)
Rhode Island (33)
South America (1121)
South Carolina (22)
South Dakota (1)
Southern California (2300)
Tennessee (101)
Texas (908)
Utah (181)
Virginia (146)
Washington D.C. (62)
Washington State (560)
West Virginia (3)
Wisconsin (53)
708,200 Results for "xeris biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025
February 27, 2025
·
2 min read
Press Releases
Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance
March 6, 2025
·
15 min read
Business
Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events
Xeris Biopharma Holdings, Inc. announced financial results for the first quarter ended March 31, 2024 and recent events.
May 9, 2024
·
10 min read
Press Releases
Xeris Announces Changes to Its Board of Directors
March 31, 2025
·
5 min read
BioMidwest
Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Xeris Biopharma Holdings, Inc. announced that Paul R. Edick, Xeris’ Chairman and CEO, will present an overview of the Company at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024 at 11:00 am Eastern Time.
April 2, 2024
·
1 min read
Business
Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024
Xeris Biopharma Holdings, Inc. announced that the Company will release its first quarter 2024 financial results before the open of the U.S. financial markets on Thursday, May 9, 2024.
May 2, 2024
·
2 min read
Press Releases
Xeris Biopharma Reports Third Quarter 2024 Financial Results
November 8, 2024
·
11 min read
Drug Development
Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)
Xeris Biopharma Holdings today announced topline results from its recently completed Phase 2 multi-center, open label, study of XP-8121 for the treatment of adults with hypothyroidism.
May 30, 2024
·
10 min read
Business
Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
Xeris Biopharma Holdings, Inc. announced financial results for the fourth quarter and full-year ended December 31, 2023 and recent events.
March 6, 2024
·
13 min read
BioMidwest
Xeris Biopharma Updates Its Outlook for 2023
Xeris Biopharma Holdings, Inc. today announced that, in connection with investor meetings the Company is planning to conduct next week in San Francisco, it has updated its outlook for full year 2023.
January 4, 2024
·
5 min read
1 of 70,820
Next
